6-[5-amino-3-(4-morpholin-4-ylanilino)-1,2,4-triazol-1-yl]pyridine-3-carboxamide;3-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-[2-(dimethylamino)ethyl]-4-methoxybenzamide;3-N-(2-chloro-5-methoxyphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(2,5-dimethoxyphenyl)-1-[6-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazole-3,5-diamine
C67H72ClF3N28O7 — CID 158592424
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[5-amino-3-(4-morpholin-4-ylanilino)-1,2,4-triazol-1-yl]pyridine-3-carboxamide;3-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-[2-(dimethylamino)ethyl]-4-methoxybenzamide;3-N-(2-chloro-5-methoxyphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(2,5-dimethoxyphenyl)-1-[6-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazole-3,5-diamine
6-[5-amino-3-(4-morpholin-4-ylanilino)-1,2,4-triazol-1-yl]pyridine-3-carboxamide;3-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-[2-(dimethylamino)ethyl]-4-methoxybenzamide;3-N-(2-chloro-5-methoxyphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(2,5-dimethoxyphenyl)-1-[6-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazole-3,5-diamine (PubChem CID 158592424) has the molecular formula C67H72ClF3N28O7 and a molecular weight of 1473.95 g/mol. Its IUPAC name is 6-[5-amino-3-(4-morpholin-4-ylanilino)-1,2,4-triazol-1-yl]pyridine-3-carboxamide;3-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-[2-(dimethylamino)ethyl]-4-methoxybenzamide;3-N-(2-chloro-5-methoxyphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(2,5-dimethoxyphenyl)-1-[6-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazole-3,5-diamine.
Molecular Properties
| Compound Name | 6-[5-amino-3-(4-morpholin-4-ylanilino)-1,2,4-triazol-1-yl]pyridine-3-carboxamide;3-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-[2-(dimethylamino)ethyl]-4-methoxybenzamide;3-N-(2-chloro-5-methoxyphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(2,5-dimethoxyphenyl)-1-[6-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazole-3,5-diamine |
|---|---|
| PubChem CID | 158592424 |
| Molecular Formula | C67H72ClF3N28O7 |
| Molecular Weight | 1473.95 g/mol |
| Exact Mass | 1472.58 |
| IUPAC Name | 6-[5-amino-3-(4-morpholin-4-ylanilino)-1,2,4-triazol-1-yl]pyridine-3-carboxamide;3-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-[2-(dimethylamino)ethyl]-4-methoxybenzamide;3-N-(2-chloro-5-methoxyphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(2,5-dimethoxyphenyl)-1-[6-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazole-3,5-diamine |
| SMILES | COc1ccc(C(=O)NCCN(C)C)cc1Nc1nc(N)n(-c2ccccn2)n1.COc1ccc(Cl)c(Nc2nc(N)n(-c3ccccn3)n2)c1.COc1ccc(OC)c(Nc2nc(N)n(-c3cccc(C(F)(F)F)n3)n2)c1.NC(=O)c1ccc(-n2nc(Nc3ccc(N4CCOCC4)cc3)nc2N)nc1 |
| InChI | InChI=1S/C19H24N8O2.C18H20N8O2.C16H15F3N6O2.C14H13ClN6O/c1-26(2)11-10-22-17(28)13-7-8-15(29-3)14(12-13)23-19-24-18(20)27(25-19)16-6-4-5-9-21-16;19-16(27)12-1-6-15(21-11-12)26-17(20)23-18(24-26)22-13-2-4-14(5-3-13)25-7-9-28-10-8-25;1-26-9-6-7-11(27-2)10(8-9)21-15-23-14(20)25(24-15)13-5-3-4-12(22-13)16(17,18)19;1-22-9-5-6-10(15)11(8-9)18-14-19-13(16)21(20-14)12-4-2-3-7-17-12/h4-9,12H,10-11H2,1-3H3,(H,22,28)(H3,20,23,24,25);1-6,11H,7-10H2,(H2,19,27)(H3,20,22,23,24);3-8H,1-2H3,(H3,20,21,23,24);2-8H,1H3,(H3,16,18,19,20) |
| InChIKey | HUPKGUIOTFBMMQ-UHFFFAOYSA-N |
| XLogP | 7.89 |
| TPSA | 451.42 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 106 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1473.95 |
| LogP ≤ 5 | 7.89 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158592424 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.